NCT00897169View on ClinicalTrials.gov

A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

271

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
OTHER

Oral Glucose Tolerance Test (OGTT)

A 5-hour oral glucose tolerance test (OGTT) is performed at visit 2

OTHER

Euglycaemic hyperinsulinaemic clamp

A 4-hour euglycaemic, hyperinsulinaemic clamp is performed at visit 3

Trial Locations (2)

2100

Novo Nordisk Investigational Site, København Ø

113-8655

Novo Nordisk Investigational Site, Tokyo

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT00897169 - A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects | Biotech Hunter | Biotech Hunter